Year |
Citation |
Score |
2021 |
Halvey P, Farutin V, Koppes L, Gunay NS, Pappas DA, Manning AM, Capila I. Variable blood processing procedures contribute to plasma proteomic variability. Clinical Proteomics. 18: 5. PMID 33468058 DOI: 10.1186/s12014-021-09311-3 |
0.677 |
|
2019 |
Farutin V, Prod'homme T, McConnell K, Washburn N, Halvey P, Etzel CJ, Guess J, Duffner J, Getchell K, Meccariello R, Gutierrez B, Honan C, Zhao G, Cilfone NA, Gunay NS, ... ... Capila I, et al. Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor. Arthritis Research & Therapy. 21: 216. PMID 31647025 DOI: 10.1186/S13075-019-1999-3 |
0.683 |
|
2019 |
Lech M, Guess J, Duffner J, Oyamada J, Shimizu C, Hoshino S, Farutin V, Bulik DA, Gutierrez B, Sarvaiya H, Kapoor B, Koppes L, Saldova R, Stockmann H, Albrecht S, ... ... Capila I, et al. Circulating Markers of Inflammation Persist in Children and Adults with Giant Aneurysms after Kawasaki Disease. Circulation. Genomic and Precision Medicine. PMID 30844302 DOI: 10.1161/CIRCGEN.118.002433 |
0.663 |
|
2018 |
Washburn N, Meccariello R, Duffner J, Getchell K, Holte K, Prod'homme T, Srinivasan K, Prenovitz R, Lansing J, Capila I, Kaudinya G, Manning AM, Bosques CJ. Characterization of endogenous human FcγRIII by mass spectrometry reveals site, allele and sequence specific glycosylation. Molecular & Cellular Proteomics : McP. PMID 30559323 DOI: 10.1074/Mcp.Ra118.001142 |
0.325 |
|
2017 |
Yu F, Qiao J, Robblee J, Tsao D, Anderson J, Capila I. An Integrated Approach to Unique NMR Assignment of Methionine Methyl Resonances in Proteins. Analytical Chemistry. 89: 1610-1616. PMID 28208280 DOI: 10.1021/Acs.Analchem.6B03705 |
0.306 |
|
2016 |
Ortiz DF, Lansing JC, Rutitzky L, Kurtagic E, Prod'homme T, Choudhury A, Washburn N, Bhatnagar N, Beneduce C, Holte K, Prenovitz R, Child M, Killough J, Tyler S, Brown J, ... ... Capila I, et al. Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors. Science Translational Medicine. 8: 365ra158. PMID 27856797 DOI: 10.1126/Scitranslmed.Aaf9418 |
0.3 |
|
2016 |
Beccati D, Lech M, Ozug J, Gunay NS, Wang J, Sun EY, Pradines JR, Farutin V, Shriver Z, Kaundinya GV, Capila I. An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure. Glycoconjugate Journal. PMID 27771794 DOI: 10.1007/S10719-016-9734-7 |
0.732 |
|
2016 |
Pradines JR, Beccati D, Lech M, Ozug J, Farutin V, Huang Y, Gunay NS, Capila I. Combining measurements to estimate properties and characterization extent of complex biochemical mixtures; applications to Heparan Sulfate. Scientific Reports. 6: 24829. PMID 27112127 DOI: 10.1038/Srep24829 |
0.7 |
|
2015 |
Lech M, Capila I, Kaundinya GV. Mass spectrometric methods for the analysis of heparin and heparan sulfate. Methods in Molecular Biology (Clifton, N.J.). 1229: 119-28. PMID 25325949 DOI: 10.1007/978-1-4939-1714-3_12 |
0.355 |
|
2014 |
Roy S, El Hadri A, Richard S, Denis F, Holte K, Duffner J, Yu F, Galcheva-Gargova Z, Capila I, Schultes B, Petitou M, Kaundinya GV. Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies. Journal of Medicinal Chemistry. 57: 4511-20. PMID 24786387 DOI: 10.1021/Jm4016069 |
0.409 |
|
2014 |
Yu F, Roy S, Arevalo E, Schaeck J, Wang J, Holte K, Duffner J, Gunay NS, Capila I, Kaundinya GV. Characterization of heparin-protein interaction by saturation transfer difference (STD) NMR. Analytical and Bioanalytical Chemistry. 406: 3079-89. PMID 24664406 DOI: 10.1007/S00216-014-7729-4 |
0.721 |
|
2012 |
Beccati D, Roy S, Lech M, Ozug J, Schaeck J, Gunay NS, Zouaoui R, Capila I, Kaundinya GV. Identification of a novel structure in heparin generated by sequential oxidative-reductive treatment. Analytical Chemistry. 84: 5091-6. PMID 22624650 DOI: 10.1021/Ac3007494 |
0.734 |
|
2012 |
Ozug J, Wudyka S, Gunay NS, Beccati D, Lansing J, Wang J, Capila I, Shriver Z, Kaundinya GV. Structural elucidation of the tetrasaccharide pool in enoxaparin sodium Analytical and Bioanalytical Chemistry. 403: 2733-2744. PMID 22610547 DOI: 10.1007/S00216-012-6045-0 |
0.731 |
|
2012 |
Shriver Z, Capila I, Venkataraman G, Sasisekharan R. Heparin and heparan sulfate: analyzing structure and microheterogeneity. Handbook of Experimental Pharmacology. 159-76. PMID 22566225 DOI: 10.1007/978-3-642-23056-1_8 |
0.356 |
|
2010 |
Beccati D, Roy S, Yu F, Gunay NS, Capila I, Lech M, Linhardt RJ, Venkataraman G. Identification of a novel structure in heparin generated by potassium permanganate oxidation. Carbohydrate Polymers. 82: 699-705. PMID 25147414 DOI: 10.1016/J.Carbpol.2010.05.038 |
0.747 |
|
2009 |
Prabhakar V, Capila I, Sasisekharan R. The structural elucidation of glycosaminoglycans. Methods in Molecular Biology (Clifton, N.J.). 534: 147-56. PMID 19277554 DOI: 10.1007/978-1-59745-022-5_11 |
0.361 |
|
2009 |
Prabhakar V, Capila I, Sasisekharan R. Glycosaminoglycan characterization methodologies: probing biomolecular interactions. Methods in Molecular Biology (Clifton, N.J.). 534: 331-40. PMID 19277541 DOI: 10.1007/978-1-59745-022-5_23 |
0.375 |
|
2009 |
Prabhakar V, Capila I, Soundararajan V, Raman R, Sasisekharan R. Recombinant expression, purification, and biochemical characterization of chondroitinase ABC II from Proteus vulgaris. The Journal of Biological Chemistry. 284: 974-82. PMID 18849565 DOI: 10.1074/Jbc.M806630200 |
0.346 |
|
2008 |
Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nature Biotechnology. 26: 669-75. PMID 18437154 DOI: 10.1038/Nbt1407 |
0.712 |
|
2006 |
Prabhakar V, Capila I, Raman R, Srinivasan A, Bosques CJ, Pojasek K, Wrick MA, Sasisekharan R. The catalytic machinery of chondroitinase ABC I utilizes a calcium coordination strategy to optimally process dermatan sulfate. Biochemistry. 45: 11130-9. PMID 16964974 DOI: 10.1021/Bi0605484 |
0.308 |
|
2005 |
Prabhakar V, Raman R, Capila I, Bosques CJ, Pojasek K, Sasisekharan R. Biochemical characterization of the chondroitinase ABC I active site. The Biochemical Journal. 390: 395-405. PMID 16108757 DOI: 10.1042/Bj20050532 |
0.303 |
|
2005 |
Prabhakar V, Capila I, Bosques CJ, Pojasek K, Sasisekharan R. Chondroitinase ABC I from Proteus vulgaris: cloning, recombinant expression and active site identification. The Biochemical Journal. 386: 103-12. PMID 15691229 DOI: 10.1042/Bj20041222 |
0.318 |
|
2005 |
Shriver Z, Capila I, Gunay NS, Venkataraman G. Sequencing complex polysaccharides Chimica Oggi. 23: 24-26. DOI: 10.1126/Science.286.5439.537 |
0.679 |
|
2005 |
Capila I, Gunay NS, Shriver Z, Venkataraman G. Methods for structural analysis of heparin and heparan sulfate Chemistry and Biology of Heparin and Heparan Sulfate. 55-77. DOI: 10.1016/B978-008044859-6/50004-6 |
0.703 |
|
2002 |
Capila I, Linhardt RJ. Heparin-protein interactions. Angewandte Chemie (International Ed. in English). 41: 391-412. PMID 12491369 DOI: 10.1002/1521-3773(20020201)41:3<390::Aid-Anie390>3.0.Co;2-B |
0.5 |
|
2002 |
Garg HG, Cindhuchao N, Quinn DA, Hales CA, Thanawiroon C, Capila I, Linhardt RJ. Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation. Carbohydrate Research. 337: 2359-64. PMID 12433502 DOI: 10.1016/S0008-6215(02)00190-8 |
0.723 |
|
2002 |
Capila I, Wu Y, Rethwisch DW, Matte A, Cygler M, Linhardt RJ. Role of arginine 292 in the catalytic activity of chondroitin AC lyase from Flavobacterium heparinum. Biochimica Et Biophysica Acta. 1597: 260-70. PMID 12044904 DOI: 10.1016/S0167-4838(02)00304-7 |
0.48 |
|
2002 |
Ma Q, Dudas B, Daud A, Iqbal O, Hoppensteadt D, Jeske W, Cornelli U, Lee J, Lorens S, Mervis R, Hanin I, Capila I, Linhardt R, Fareed J. Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3. Thrombosis Research. 105: 303-9. PMID 12031824 DOI: 10.1016/S0049-3848(01)00413-3 |
0.432 |
|
2002 |
Capila I, Linhardt RJ. Heparin-Protein-Wechselwirkungen Angewandte Chemie. 114: 426-450. DOI: 10.1002/1521-3757(20020201)114:3<426::Aid-Ange426>3.0.Co;2-Q |
0.4 |
|
2001 |
Ye S, Luo Y, Lu W, Jones RB, Linhardt RJ, Capila I, Toida T, Kan M, Pelletier H, McKeehan WL. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry. 40: 14429-39. PMID 11724555 DOI: 10.1021/Bi011000U |
0.477 |
|
2001 |
Libeu CP, Lund-Katz S, Phillips MC, Wehrli S, Hernáiz MJ, Capila I, Linhardt RJ, Raffaï RL, Newhouse YM, Zhou F, Weisgraber KH. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. The Journal of Biological Chemistry. 276: 39138-44. PMID 11500500 DOI: 10.1074/Jbc.M104746200 |
0.5 |
|
2001 |
Capila I, Hernáiz MJ, Mo YD, Mealy TR, Campos B, Dedman JR, Linhardt RJ, Seaton BA. Annexin V--heparin oligosaccharide complex suggests heparan sulfate--mediated assembly on cell surfaces. Structure (London, England : 1993). 9: 57-64. PMID 11342135 DOI: 10.1016/S0969-2126(00)00549-9 |
0.478 |
|
2001 |
Dong J, Peters-Libeu CA, Weisgraber KH, Segelke BW, Rupp B, Capila I, Hernáiz MJ, LeBrun LA, Linhardt RJ. Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry. 40: 2826-34. PMID 11258893 DOI: 10.1021/Bi002417N |
0.708 |
|
2000 |
Hiebert LM, Wice SM, Ping T, Hileman RE, Capila I, Linhardt RJ. Tissue distribution and antithrombotic activity of unlabeled or 14C-labeled porcine intestinal mucosal heparin following administration to rats by the oral route. Canadian Journal of Physiology and Pharmacology. 78: 307-20. PMID 10772058 DOI: 10.1139/Cjpp-78-4-307 |
0.415 |
|
1999 |
Garg HG, Joseph PA, Thompson BT, Hales CA, Toida T, Imanari T, Capila I, Linhardt RJ. Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation. Archives of Biochemistry and Biophysics. 371: 228-33. PMID 10545209 DOI: 10.1006/Abbi.1999.1456 |
0.471 |
|
1999 |
Capila I, VanderNoot VA, Mealy TR, Seaton BA, Linhardt RJ. Interaction of heparin with annexin V. Febs Letters. 446: 327-30. PMID 10100868 DOI: 10.1016/S0014-5793(99)00245-8 |
0.72 |
|
1998 |
Bazin HG, Capila I, Linhardt RJ. Conformational study of synthetic delta 4-uronate monosaccharides and glycosaminoglycan-derived disaccharides. Carbohydrate Research. 309: 135-44. PMID 9741074 DOI: 10.1016/S0008-6215(98)00118-9 |
0.417 |
|
1997 |
Wang H, Toida T, Kim YS, Capila I, Hileman RE, Bernfield M, Linhardt RJ. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding. Biochemical and Biophysical Research Communications. 235: 369-73. PMID 9199199 DOI: 10.1006/Bbrc.1997.6789 |
0.682 |
|
Show low-probability matches. |